CLINICAL_TRIALS
trial_result
· 2024-02-28
Clinical Trial Update: MicroRNA Activation of LOX-1 Mechanisms in Endometriosis [Phase 4]
Summary
A Phase 4 clinical trial investigating microRNA activation of LOX-1 mechanisms in endometriosis was terminated, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Penn State University | Conditions: Endometriosis | Phase 4 | Status: TERMINATED | Results posted: 2024-02-28